Arkolith/Insider Trading/CYT/Form 4

Gaiero David G

Chief Financial OfficerCyteir Therapeutics, Inc. (CYT) · full profile →Form 4 · filed Feb 7, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 13, 2023Grant(A)5K$1.49$7K9K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 3, 2023Grant(A)114K—$0114K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-007536) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML